Inhibition of Aortic CX3CR1+ Macrophages Mitigates Thoracic Aortic Aneurysm Progression in Marfan Syndrome in Mice

Overview

Journal J Clin Invest

Date 2025 Jan 16

PMID 39817456

Authors

Jiaqi Huang

Hao Liu

Zhujiang Liu

Zhenting Wang

Hanshi Xu

Zhuofan Li

Shan Huang

Xueyuan Yang

Yicong Shen

Fang Yu

Yulin Li

Junming Zhu

Wei Li

Li Wang

Wei Kong

Yi Fu

Affiliations

Soon will be listed here.

Abstract

The pathogenesis of thoracic aortic aneurysm (TAA) in Marfan syndrome (MFS) is generally attributed to vascular smooth muscle cell (VSMC) pathologies. However, the role of immune cell-mediated inflammation remains elusive. Single-cell RNA sequencing identified a subset of CX3CR1+ macrophages mainly located in the intima in the aortic roots and ascending aortas of Fbn1C1041G/+ mice, further validated in MFS patients. Specific elimination of CX3CR1+ cells by diphtheria toxin in Cx3cr1-CreERT2iDTRF/+Fbn1C1041G/+ mice efficiently ameliorated TAA progression. Administering the monoclonal antibodies to respectively neutralize TNF-α and IGF1 produced by CX3CR1+ cells from MFS patients greatly suppressed the cocultured MFS patient-specific induced pluripotent stem cell-derived VSMC inflammation. BM transplantation and parabiosis revealed that CX3CR1+ macrophages are mainly originated from BM-derived monocytes. Targeting TNF-α and IGF1 in CX3CR1+ macrophages via shRNA lentivirus transduction in BM cells efficiently suppressed TAA development in BM-transplanted Fbn1C1041G/+ mice. Application of the CCR2 antagonist RS504393 to inhibit monocyte infiltration markedly reduced the accumulation of CX3CR1+ macrophages and subsequently alleviated TAA progression in Fbn1C1041G/+ mice. In summary, CX3CR1+ macrophages mainly located in aortic intima mediate TAA formation by paracrinally causing VSMC inflammation, and targeting them offers a potential antiinflammatory therapeutic strategy for MFS-related TAA.

References

Hofmann Bowman M, Eagle K, Milewicz D . Update on Clinical Trials of Losartan With and Without β-Blockers to Block Aneurysm Growth in Patients With Marfan Syndrome: A Review. JAMA Cardiol. 2019; 4(7):702-707. DOI: 10.1001/jamacardio.2019.1176. View

Martin K, Merenick B, Ding M, Fetalvero K, Rzucidlo E, Kozul C . Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling. J Biol Chem. 2007; 282(49):36112-20. DOI: 10.1074/jbc.M703914200. View

Chung A, Au Yeung K, Cortes S, Sandor G, Judge D, Dietz H . Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome. Br J Pharmacol. 2007; 150(8):1075-83. PMC: 2013910. DOI: 10.1038/sj.bjp.0707181. View

Lim W, Dong J, Ng B, Widjaja A, Xie C, Su L . Inhibition of IL11 Signaling Reduces Aortic Pathology in Murine Marfan Syndrome. Circ Res. 2022; 130(5):728-740. DOI: 10.1161/CIRCRESAHA.121.320381. View

Harrison S, Smith A, Jones G, Swerdlow D, Rampuri R, Bown M . Interleukin-6 receptor pathways in abdominal aortic aneurysm. Eur Heart J. 2012; 34(48):3707-16. PMC: 3869968. DOI: 10.1093/eurheartj/ehs354. View

Pitcher A, Spata E, Emberson J, Davies K, Halls H, Holland L . Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials. Lancet. 2022; 400(10355):822-831. PMC: 7613630. DOI: 10.1016/S0140-6736(22)01534-3. View

Radonic T, DE Witte P, Groenink M, de Bruin-Bon R, Timmermans J, Scholte A . Critical appraisal of the revised Ghent criteria for diagnosis of Marfan syndrome. Clin Genet. 2011; 80(4):346-53. DOI: 10.1111/j.1399-0004.2011.01646.x. View

Jimenez-Altayo F, Siegert A, Bonorino F, Meirelles T, Barbera L, Dantas A . Differences in the Thoracic Aorta by Region and Sex in a Murine Model of Marfan Syndrome. Front Physiol. 2017; 8:933. PMC: 5694786. DOI: 10.3389/fphys.2017.00933. View

Zhang F, Tsai S, Kato K, Yamanouchi D, Wang C, Rafii S . Transforming growth factor-beta promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells. J Biol Chem. 2009; 284(26):17564-74. PMC: 2719395. DOI: 10.1074/jbc.M109.013987. View

10.

Ju X, Ijaz T, Sun H, LeJeune W, Vargas G, Shilagard T . IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR/mgR mouse model of severe Marfan syndrome. J Am Heart Assoc. 2014; 3(1):e000476. PMC: 3959679. DOI: 10.1161/JAHA.113.000476. View

11.

Ensan S, Li A, Besla R, Degousee N, Cosme J, Roufaiel M . Self-renewing resident arterial macrophages arise from embryonic CX3CR1(+) precursors and circulating monocytes immediately after birth. Nat Immunol. 2015; 17(2):159-68. DOI: 10.1038/ni.3343. View

12.

Granata A, Serrano F, Bernard W, McNamara M, Low L, Sastry P . An iPSC-derived vascular model of Marfan syndrome identifies key mediators of smooth muscle cell death. Nat Genet. 2016; 49(1):97-109. DOI: 10.1038/ng.3723. View

13.

Fu Y, Gao C, Liang Y, Wang M, Huang Y, Ma W . Shift of Macrophage Phenotype Due to Cartilage Oligomeric Matrix Protein Deficiency Drives Atherosclerotic Calcification. Circ Res. 2016; 119(2):261-76. DOI: 10.1161/CIRCRESAHA.115.308021. View

14.

Schloss M, Hilby M, Nitz K, Guillamat Prats R, Ferraro B, Leoni G . Ly6C Monocytes Oscillate in the Heart During Homeostasis and After Myocardial Infarction-Brief Report. Arterioscler Thromb Vasc Biol. 2017; 37(9):1640-1645. DOI: 10.1161/ATVBAHA.117.309259. View

15.

Franca C, Izar M, Hortencio M, do Amaral J, Ferreira C, Tuleta I . Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease. Clin Sci (Lond). 2017; 131(12):1215-1224. DOI: 10.1042/CS20170009. View

16.

Liu X, Chen W, Zhu G, Yang H, Li W, Luo M . Single-cell RNA sequencing identifies an Il1rn/Trem1 macrophage subpopulation as a cellular target for mitigating the progression of thoracic aortic aneurysm and dissection. Cell Discov. 2022; 8(1):11. PMC: 8821555. DOI: 10.1038/s41421-021-00362-2. View

17.

Chen H, Mester T, Raychaudhuri N, Kauh C, Gupta S, Smith T . Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes. J Clin Endocrinol Metab. 2014; 99(9):E1635-40. PMC: 4154099. DOI: 10.1210/jc.2014-1580. View

18.

Tieu B, Lee C, Sun H, LeJeune W, Recinos 3rd A, Ju X . An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest. 2009; 119(12):3637-51. PMC: 2786788. DOI: 10.1172/JCI38308. View

19.

Oller J, Mendez-Barbero N, Josue Ruiz E, Villahoz S, Renard M, Canelas L . Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome. Nat Med. 2017; 23(2):200-212. DOI: 10.1038/nm.4266. View

20.

Cochain C, Vafadarnejad E, Arampatzi P, Pelisek J, Winkels H, Ley K . Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis. Circ Res. 2018; 122(12):1661-1674. DOI: 10.1161/CIRCRESAHA.117.312509. View